These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21069517)

  • 1. An unusual case of allopurinol hypersensitivity syndrome potentiated by intravitreal bevacizumab.
    Padhy BM; Gupta YK; Shanmugam SP; Bamrolia NR
    Eur J Clin Pharmacol; 2011 May; 67(5):537-8. PubMed ID: 21069517
    [No Abstract]   [Full Text] [Related]  

  • 2. Angioedema after intravitreal bevacizumab injection.
    Toklu Y; Sarac O; Berk S; Simsek S
    Cutan Ocul Toxicol; 2012 Mar; 31(1):85-6. PubMed ID: 22309281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hand eruption after intravenous administration of bevacizumab.
    Ruiz V; Garcia-Muret MP; Alomar A
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):238-9. PubMed ID: 20477919
    [No Abstract]   [Full Text] [Related]  

  • 4. Allopurinol hypersensitivity. A case report.
    Stein CM
    S Afr Med J; 1985 Jun; 67(23):935-6. PubMed ID: 3159106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity.
    Shah PK; Morris RJ; Narendran V; Kalpana N
    Indian J Ophthalmol; 2011; 59(1):73-4. PubMed ID: 21157086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Allopurinol-induced hypersensitivity syndrome].
    Kinyó A; Lakatos A; Varga A; Gyulai R; Varga E; Bata-Csörgő Z; Kemény L
    Orv Hetil; 2012 Apr; 153(15):586-91. PubMed ID: 22472359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The allopurinol hypersensitivity syndrome.
    Pluim HJ; van Deuren M; Wetzels JF
    Neth J Med; 1998 Mar; 52(3):107-10. PubMed ID: 9599967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allopurinol hypersensitivity syndrome].
    Gram JT; Gundersen T
    Tidsskr Nor Laegeforen; 1989 Oct; 109(30):3102-4. PubMed ID: 2815042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual case of hypersensitivity vasculitis probably due to allopurinol.
    Falco D; Daniels RA; Conklin R
    J Med Soc N J; 1982 May; 79(5):409-12. PubMed ID: 6954286
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations].
    Małgorzata F
    Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death following allopurinol hypersensitivity syndrome.
    Hanger HC; Pillans PI
    N Z Med J; 1994 Jun; 107(979):229. PubMed ID: 8208488
    [No Abstract]   [Full Text] [Related]  

  • 12. [Allopurinol hypersensitivity syndrome].
    Rivas González P; Calvo Hernández R; Molinelli Barranco M; Díaz Curiel M
    Rev Clin Esp; 2001 Aug; 201(8):493. PubMed ID: 11599172
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections.
    Adelman RA; Zheng Q; Mayer HR
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):105-10. PubMed ID: 20187807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allpurinol hypersensitivity syndrome: effects and treatment.
    Lindsey SW; Evans EF
    Va Med; 1978 Apr; 105(4):297-9. PubMed ID: 645192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic alternatives in a patient with DRESS syndrome induced by allopurinol.
    Calogiuri GF; Satriano F; Muratore L; Valacca A; Nettis E; Di Leo E; Vacca A
    J Investig Allergol Clin Immunol; 2009; 19(4):333-4. PubMed ID: 19639739
    [No Abstract]   [Full Text] [Related]  

  • 16. Spectral domain optical coherence tomography features of multiple subfoveal retinal pigment epithelial tears after intravitreal bevacizumab.
    Chalam KV; Murthy RK; Gupta SK; Brar VS
    Indian J Ophthalmol; 2011; 59(1):47-8. PubMed ID: 21157072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality.
    Singer JZ; Wallace SL
    Arthritis Rheum; 1986 Jan; 29(1):82-7. PubMed ID: 3947418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of sterile endophthalmitis after repeated intravitreal bevacizumab injection.
    Yenerel NM; Dinc UA; Gorgun E
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):362-3. PubMed ID: 18476807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALLERGIC REACTION UPON INTRAVITREAL ADMINISTRATION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS.
    Meredith GG; Schkade PA; Joondeph BC
    Retin Cases Brief Rep; 2019 Summer; 13(3):287-289. PubMed ID: 28301410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The allopurinol hypersensitivity syndrome.
    Lupton GP; Odom RB
    J Am Acad Dermatol; 1979 Oct; 1(4):365-74. PubMed ID: 159913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.